Findings

What do systematic reviews say?

3 questions · 3 findings · 1 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 2 · 66.7%GRADE not reported 0 · 0%Very low 1 · 33.3%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Dihydropyridine calcium channel blockers vs other antihypertensives

Other side effects · people with CKD requiring dialysis

The review found no eligible studies for this question.

1 finding from 1 review

Calcium channel blockers for people with chronic kidney disease requiring dialysis 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Dihydropyridine calcium channel blockers vs placebo or control

Other side effects · people with CKD requiring dialysis

The review found no eligible studies for this question.

1 finding from 1 review

Calcium channel blockers for people with chronic kidney disease requiring dialysis 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Dihydropyridine vs non‐dihydropyridine calcium channel blockers

Other side effects1,5 · people with CKD requiring dialysis

It is very uncertain whether dihydropyridine changes other side effects1,5 compared with non‐dihydropyridine calcium channel blockers (very low certainty).

1 finding from 1 review

Calcium channel blockers for people with chronic kidney disease requiring dialysis 2020 · Cochrane Headline outcomes only
RR 0.13 [0.01, 2.36]
1 study · 40 participants
Very low